FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On March 2, 2005
Table of Contents
Docket # Title
1999P-0485 Rescind Approval of Subtherapeutic Antibiotic Use Livestock
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
2004D-0369 Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
2004D-0459 Guidance for Industry on Pharmacokinetics in Pregnancy Study Design, Data Analysis, and Impact on Dosing and Labeling
2004N-0454 Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
2004N-0479 Draft Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals; Availability
2004N-0559 Overall benefit to risk considerations for Cox-2 selective nonsteroidal anti-inflammatory drugs and related agents
2004P-0329 Request Public Hearings regarding the sales, distribution and use of hand-held Doppler fetoscopes
2004P-0349 Action on Products containing added Mercury
2005N-0038 Reporting of Adverse Events to Institutional Review Boards; Public Hearing
1999P-0485 Rescind Approval of Subtherapeutic Antibiotic Use Livestock
C 3644 M. Ewing,DVM,MS,MAM,ACPV and P. Stayer,DVM,MS,ACPV Vol #: 217
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
EXB 1119 Bayer Corporation Vol #: 480
2004D-0369 Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
EMC 1051 B Banever Vol #: 14
EMC 1052 J LeViness Vol #: 14
EMC 1053 Foundation for Nutritional Therapy and Applications Vol #: 14
EMC 1054 C Banever Vol #: 14
EMC 1055 F Chen Vol #: 14
EMC 1056 M Bray Vol #: 14
EMC 1057 R Kowalski Vol #: 14
EMC 1058 L Laure Vol #: 14
EMC 1059 M Pieri Vol #: 14
EMC 1060 S Rajan Vol #: 14
EMC 1061 K Beaulieu Vol #: 14
EMC 1062 R Miller Vol #: 14
EMC 1063 M Cooper Vol #: 14
EMC 1064 Somerset Invertebrates Group & Christchuch Harbour Ornithological Society Vol #: 14
EMC 1065 T Batley Vol #: 14
EMC 1066 J White Vol #: 14
EMC 1067 P White Vol #: 14
EMC 1068 E Utschig Vol #: 14
EMC 1069 N Reinstein Vol #: 14
EMC 1070 N Smukler Vol #: 14
2004D-0459 Guidance for Industry on Pharmacokinetics in Pregnancy Study Design, Data Analysis, and Impact on Dosing and Labeling
C 7 Eli Lilly and Company (Lilly) Vol #: 1
2004N-0454 Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
C 53 D. Brown Vol #: 30
C 54 C. McAlllister Vol #: 30
C 55 L. Mills et al. Vol #: 30
C 56 H. Morie Vol #: 30
C 57 R. Fahringer, Jr. Vol #: 30
C 58 K. Aisup Vol #: 30
C 59 K. Goodrich Vol #: 30
C 60 K. Goodwrich Vol #: 30
C 61 D. Johnson Vol #: 30
C 62 L. Blugrind Vol #: 30
C 63 R. Ucci, MD Vol #: 30
C 64 M. Lynn et al Vol #: 30
C 65 J. Godat, MD Vol #: 30
C 66 M. Boggia Vol #: 30
C 67 C. Loehlein Vol #: 30
C 68 J. Cholewa Vol #: 30
C 69 J and P Horn Vol #: 30
C 70 T. Willis Vol #: 30
C 71 P. Maffeo, PhD Vol #: 30
C 72 L. Smith Vol #: 30
C 73 C. Albert Vol #: 30
C 74 R. Redinger Vol #: 30
C 75 L. Jaeggli Vol #: 30
C 76 S. Giuliano Vol #: 30
C 77 E and D Backholm Vol #: 30
C 78 D. Weber Vol #: 30
C 79 P. Suffredini Vol #: 30
C 80 F and G Hulce Vol #: 30
C 81 Moore, Winter, Skebba & McLennan, LLP Vol #: 30
C 82 P. Bueltel Vol #: 30
C 83 R. Good Vol #: 30
C 84 J. Kane Vol #: 30
C 85 M. Sarazin Vol #: 30
C 86 K. Moretti Vol #: 30
C 87 S. Froehlich, MAcOM, LAc Vol #: 30
C 88 N. Narcowich Vol #: 30
C 89 E. Terry Vol #: 30
C 90 M. Cottle Vol #: 30
C 91 B. Kotwica Vol #: 30
C 92 F. Guros Vol #: 30
C 93 J. Guenthner Vol #: 30
C 94 C and D Hamm Vol #: 30
C 95 R. Krolo Vol #: 30
C 96 O. Markowitz, L.Ac. Vol #: 30
C 97 S. Froehlich, LAc Vol #: 30
C 98 V. Quest Vol #: 30
C 99 M. Brancato Vol #: 30
C 100 M. Rodriguez, MD Vol #: 30
C 101 H. Owen Vol #: 30
C 102 W. Richardson, Jr. Vol #: 30
C 103 J. Eidenberg Vol #: 30
C 104 C and S Kinnen Vol #: 30
C 105 I Breeden Vol #: 30
C 106 B. Munguia Vol #: 30
C 107 P. Das Vol #: 30
C 108 J. Benz Vol #: 30
C 109 P. Schaffran Vol #: 30
C 110 V. Rodriguez, MD Vol #: 30
C 111 M. Ellis Vol #: 30
C 112 Eligible Vol #: 30
C 113 M. Bohr Vol #: 30
C 114 C. Montelione Vol #: 30
C 115 P. Mazzoni Vol #: 30
C 116 D. Morgan Vol #: 30
C 117 J. Slama Vol #: 30
C 118 M. James Vol #: 30
C 119 C. Biasucci Vol #: 30
C 120 P. Greb Vol #: 30
C 121 D. Mulville Vol #: 30
C 122 Illegible Vol #: 30
C 123 D. Treptow Vol #: 30
C 124 C. Crew Vol #: 31
C 125 J. Reardon, PhD Vol #: 31
C 126 D. Mulville Vol #: 31
C 127 Mr and Mrs A Prittman Vol #: 31
C 128 Eligible Vol #: 31
C 129 R. Buchacher Vol #: 31
C 130 A. Flynn Vol #: 31
C 131 A. Whitling Vol #: 31
C 132 M. Bandstra, RN Vol #: 31
C 133 F. Jansen Vol #: 31
C 134 D. Price Vol #: 31
C 135 Mr and Mrs I and L Griese Vol #: 31
C 136 D. Price Vol #: 31
C 137 G. Uransky Vol #: 31
C 138 G. Hansen Vol #: 31
C 139 S. Egdal Vol #: 31
C 140 S. Showers Vol #: 31
C 141 R. Bohyer Vol #: 31
C 142 A. Wenthing Vol #: 31
C 143 B. Fischer Vol #: 31
C 144 W. Webber Vol #: 31
C 145 M. Stricker Vol #: 31
C 146 S. Kinnen Vol #: 31
C 147 G. Bryce, PhD Vol #: 31
C 148 C. Carricato Vol #: 31
C 149 M. Hoogers Vol #: 31
C 150 J. Vintilla, Esq Vol #: 31
C 151 W. Webber Vol #: 31
C 152 D. Gustafson Vol #: 31
C 153 P. Maffeo, PhD Vol #: 31
C 154 J. Vintilla, Esq Vol #: 31
C 155 P. Sutton Vol #: 31
C 156 J. Shelton, RN Vol #: 31
C 157 Form Letters Vol #: 32
C 158 Form Letters Vol #: 33
C 159 Form Letters Vol #: 34
C 160 Form Letters Vol #: 35
C 161 Form Letters Vol #: 36
C 162 Form Letters Vol #: 37
C 163 Form Letters Vol #: 38
2004N-0479 Draft Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals; Availability
C 5
Attachment
Phibro Animal Health (PAH) Vol #: 1
C 6 American Veterinary Medical Assn (AVMA) Vol #: 1
C 7 Marshfield Clinic Research Foundation Vol #: 1
2004N-0559 Overall benefit to risk considerations for Cox-2 selective nonsteroidal anti-inflammatory drugs and related agents
C 11 American Academy of Orthopaedic Surgeons (AAOS) Vol #: 2
C 12 D. Garrett Vol #: 2
C 13 S.K. Eloff Vol #: 2
2004P-0329 Request Public Hearings regarding the sales, distribution and use of hand-held Doppler fetoscopes
ELET 2 Russel J Thomsen MD Vol #: 1
ELET 3 HFZ-215 to Russel J Thomsen MD Vol #: 1
2004P-0349 Action on Products containing added Mercury
LET 2 Coalition for Mercury-free Drugs (CoMeD) Vol #: 1
2005N-0038 Reporting of Adverse Events to Institutional Review Boards; Public Hearing
C 1 G. Ubogy Vol #: 1
EAPE 140 Fanaroff, Wendy Vol #: 1
EAPE 141 Pettit, Joan Vol #: 1
EAPE 142 Trunzo, Jeffrey Vol #: 1
EAPE 143 Mart, Alan Vol #: 1
EAPE 144 Schwetz, Bernard Vol #: 1
EAPE 145 Reese, Owen Vol #: 1
EAPE 146 Dickler, Howard Vol #: 1
EAPE 147 Greenberg, Karin Vol #: 1
EAPE 148 HALE, KAREN Vol #: 1
EAPE 149 Mueller, David Vol #: 1
EAPE 150 Wallman, Laurence Vol #: 1
EAPE 151 Hostelley, Linda Vol #: 1
EAPE 152 Bevan, Lynn Vol #: 1
EAPE 153 Claggett, Mary Vol #: 1

Page created on March 3, 2005 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management